Lv1
26 积分 2022-10-22 加入
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
1个月前
已完结
Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial
1个月前
已完结
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
1个月前
已完结
How I treat patients with AML using azacitidine and venetoclax
1个月前
已完结
How I treat advanced phases of CML
1个月前
已完结
Pathogenesis and management of accelerated and blast phases of chronic myeloid leukemia
1个月前
已完结
Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements
3个月前
已完结
The Novel HLA‐C*03:03:77 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual
3个月前
已完结
Medication therapy of high‐dose methotrexate: An evidence‐based practice guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society
3个月前
已完结
Ultrasensitive NGS MRD assessment in Ph+ ALL : Prognostic impact and correlation with RT‐PCR for BCR::ABL1
4个月前
已完结
皖公网安备34019202002308
